Lung Disorder clinical trials
18 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
- Housing, Environment, And Living Conditions for Transformed Health
- Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System
- Data Collection Using Eko Digital Devices in a Clinical Setting
- Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections
- Quantitative Pulmonary Imaging Registry & Biorepository
- American Lung Association (ALA) Lung Health Cohort
- Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research
- Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging
- Pivotal Study to Assess Safety and Performance of Neola®, a Novel Lung Monitoring Device for Neonates
- Service and Health Among Deployed Veterans
- Point of Care Lung Ultrasound Examination in Patients With Shortness of Breath
- Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors
- Distribution of Ventilation, Respiratory Drive and Gas Exchange: Measurements and Monitoring
- Risk Underlying Rural Areas Longitudinal Cohort Study (RURAL) Heart and Lung Study
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Lung Disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.